AviGen

Alameda, United States Founded: 1992 • Age: 34 yrs Acquired By MediciNova
Gene therapy products are developed for inherited and acquired diseases.

About AviGen

AviGen is a Healthcare company based in Alameda (United States) founded in 1992, and was acquired by MediciNova in February 2009. Gene therapy products are developed for inherited and acquired diseases. Its focus areas include Life Sciences, Rare Diseases, Drugs and Diversified. Its competitors include Moderna, BridgeBio and Spark Therapeutics; 3 of its 3 listed competitors have raised funding.

Company details

Founded in 1992 and based in Alameda, United States, operations are focused on biotechnology, specifically gene therapy for diseases such as cancer, anemia, hemophilia, hyperlipidemia, and metabolic storage disorders. Proprietary technologies including AAV vectors and the Targeted Vector Integration system are utilized to deliver genes. Treatments for blood cell-related conditions like sickle cell anemia, beta-thalassemia, and HIV infection are also advanced.

  • Headquarters Alameda, United States
  • Stage Acquired
  • Sectors
    Healthcare
  • Website avigen.com
  • Acquired by MediciNova (Feb 2009)
Key Metrics

Investors in AviGen

AviGen has secured backing from 1 investor. Prominent investors backing the company include MediciNova.

All
InvestorDescriptionFounded YearDomainLocation
Small-molecule therapeutics are developed for asthma, COPD, and neurologic diseases.
2000medicinova.comSan Diego, United States
Premium access

Investor details for AviGen

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of AviGen

2 dated milestones of AviGen across 17 years, from founding to its latest funding, stage changes and deals.

  1. Founded AviGen is founded.
  2. Exit Acquired by MediciNova.

Competitors of AviGen

AviGen has 3 listed competitors in our database, 3 of them funded. They include Moderna, BridgeBio and Spark Therapeutics.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
modernatx.com2010Cambridge, United States$2.78B1,312
mRNA-based therapeutics for diseases including cancer and infections are developed.
bridgebio.com2015Palo Alto, United States$434.2M
Therapeutics for genetic diseases are developed through targeted interventions.
sparktx.com2013Philadelphia, United States$82.8M822
Gene therapies for rare diseases including retinal dystrophies are developed.
Premium access

Detailed competitors of AviGen

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Top companies in Genomics & Gene Therapy Platforms

3 companies that operate in the same segment as AviGen (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
mRNA-based therapeutics for diseases including cancer and infections are developed.
2010Cambridge, Massachusetts, United StatesUSD 2.78 BUSD 1.94 B5,800
Digital sequencing technology for cancer detection is developed.
2012Redwood City, California, United StatesUSD 557.5 MUSD 982.02 M4,867
Circulating tumor DNA is screened for early cancer detection.
2016Menlo Park, California, United StatesUSD 2 BUSD 147.17 M1,141
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about AviGen

AviGen was founded in 1992.

AviGen is headquartered in Alameda, United States. It is registered at Alameda, California, United States.

Founded in 1992 and based in Alameda, United States, operations are focused on biotechnology, specifically gene therapy for diseases such as cancer, anemia, hemophilia, hyperlipidemia, and metabolic storage disorders. Proprietary technologies including AAV vectors and the Targeted Vector Integration system are utilized to deliver genes. Treatments for blood cell-related conditions like sickle cell anemia, beta-thalassemia, and HIV infection are also advanced.

AviGen's top competitors include Moderna, Spark Therapeutics and BridgeBio.

AviGen has 1 investor. Key investors include MediciNova.

Yes. AviGen was acquired by MediciNova in February 2009.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available